The National Trial Lawyers
  • Home
    • Meet Our Team
    • Contact Us
    • Mission & Goals
    • FAQ
  • Webinars
  • News
  • Membership Directory
    • Top 100 Map – Civil Plaintiff
    • Top 100 Map – Criminal Defense
    • Top 40 Under 40 Map – Civil Plaintiff
    • Top 40 Under 40 Map – Criminal Defense
  • Top 100
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Benefits
    • About
    • Top 100 President’s Message
    • Diplomat
    • Membership Renewal
    • Member Profile Updates
    • Top 100 Badge
    • Media
  • Top 40
    • Civil Plaintiff Officers / Executive Committee
    • Criminal Defense Officers / Executive Committee
    • Top 40 Under 40 Trial Academy Bootcamp
    • Benefits
    • About
    • Top 40 President’s Message
    • Membership Renewal
    • Member Profile Updates
    • Top 40 Badge
    • Media
  • Specialty Assoc
    • About
    • Shop
    • Officers
    • Membership Renewal
    • Member Profile Updates
    • Media
  • Nominate
    • Top 100
    • Top 40
    • Specialty Association
    • Trial Lawyer Hall of Fame
    • Trial Lawyer of the Year
    • Trial Team of the Year
    • America’s Most Influential Trial Lawyer
    • America’s Most Influential Law Firm
    • Lifetime Achievement Award
  • Shop
  • Magazine
    • A-List
  • Education and Networking Agenda
    • Trial Lawyers Summit
      • Summit Sponsors
    • Top 40 Under 40 Trial Academy Boot Camp
    • Mass Torts Made Perfect
    • The Lanier Master Class 5.0 Trial Academy 2021
    • Webinars
  • Hall of Fame
    • Trial Lawyer Hall of Fame

Jury Deliberations Underway in Pennsylvania’s 6th Transvaginal Mesh Trial

Posted on September 7, 2017 by Larry Bodine
law news, legal news, verdict, settlement

Pelvic mesh has been found to cause serious and permanent internal damage, significant pain, urinary incontinence, and repeated cases of pelvic organ prolapse.

Jury deliberations are now underway in Philadelphia, Pennsylvania, where testimony has concluded in the state’s sixth trial involving a transvaginal mesh lawsuit filed against Johnson & Johnson and its Ethicon, Inc. subsidiary.

The case, which is among more than 130 pelvic mesh lawsuits pending in a mass tort program now underway in the Philadelphia Court of Common Pleas, was filed on behalf of a woman who says Ethicon’s TVT mesh devices mangled her urethra and left her to endure life-long incontinence.

Like others pursuing transvaginal mesh lawsuits against Ethicon and Johnson & Johnson, she claims that the implants were defectively designed and alleges that the companies failed to warn doctors and patients about their potential risks. (In Re: Pelvic Mesh Litigation, Case No. 140200829.)

“We look forward to the verdict, as it may provide some clues as to how other juries might decide similar cases involving TVT transvaginal mesh devices,” says Sandy A. Liebhard, a partner at Bernstein Liebhard LLP, a nationwide law firm representing victims of defective drugs and medical devices.

Ethicon Transvaginal Mesh Litigation

Ethicon and Johnson & Johnson have so far prevailed in just one Pennsylvania transvaginal mesh trial.  Four Philadelphia juries have awarded Ethicon plaintiffs $13.6 million, 17.5 million, and $20 million in damages.

Transvaginal mesh implants are approved for use in women who suffer from pelvic organ prolapse and stress urinary incontinence. In 2008, the U.S. Food & Drug Administration (FDA) warned the implants had been associated with at least 1,000 reports of serious injuries and complications over a three-year period. In July 2011, the agency reported that complications related to transvaginal prolapse repair had tripled since 2008 and reversed its stance that such complications were rare.

In 2016, the FDA finalized regulations that reclassified pelvic mesh indicated for transvaginal prolapse repair as Class III (high risk) medical devices. The agency also made the implants ineligible for its 510(k)-clearance program, which had previously allowed transvaginal mesh manufacturers to market the products without first conducting human clinical trials.

Johnson & Johnson and Ethicon are facing more than 55,000 transvaginal mesh lawsuits in courts nationwide. Women involved in this litigation are alleged to have suffered a wide range of painful complications, including the erosion of mesh into the vaginal wall, adhesions and scarring, chronic infections, permanent pain, and incontinence, following implantation of the companies’ products.

Posted in Blog, Mass Torts

Comments are closed.

Recent Posts

Intel Ordered to Pay a $2.2B Settlement in Patent Infringement Case

Intel Ordered to Pay a $2.2B Settlement in Patent Infringement Case

March 3rd, 2021

Intel was told to pay $2.18 billion after losing a patent-infringement trial over technology related to chip-making.Intel inf[Read More...]
What is Sexual Harassment?

What is Sexual Harassment?

March 1st, 2021

Sexual Harassment Defined: Legally, sexual harassment is a form of sex discrimination that violates Title VII of the [Read More...]
Facebook Pays $650M to Settle a Privacy Dispute

Facebook Pays $650M to Settle a Privacy Dispute

March 1st, 2021

WASHINGTON: A US federal judge has given final approval to Facebook's US$650 million payment to settle a privacy dispute betw[Read More...]
Pharmaceutical Giant Johnson & Johnson is Preparing $3.9B for Talc Settlements

Pharmaceutical Giant Johnson & Johnson is Preparing $3.9B for Talc Settlements

February 26th, 2021

Pharmaceutical giant Johnson & Johnson has set aside $3.9 billion for talc-related litigation, according to a regulatory [Read More...]
Alaska Airlines Will Pay $3.19M Following the Death of a Passenger

Alaska Airlines Will Pay $3.19M Following the Death of a Passenger

February 24th, 2021

Seattle-based Alaska Airlines has been ordered to pay more than $3 million to the family of a passenger of reduced mobility w[Read More...]

Contact Us | Terms of Use | Privacy Policy

Attorney information and content provided on this website is provided for the benefit of members of The National Trial Lawyers and as a public service by Legal Associations Management, Inc. The website and all data are the property of Legal Associations Management, Inc. Data, including without limitation attorney information and content, on the site may not be mined, sold, or used commercially for any purpose without the explicit written consent of Legal Associations Management, Inc. This site may not be accessed by any automated program for extracting data for any use. By accessing and using the site you agree that you will not develop, support or use software, devices, scripts, robots, or any other means or processes (including crawlers, browser plug-ins and add-ons, or any other technology) to scrape data or otherwise copy profiles and other data. Unauthorized use or attempted unauthorized use of this system may subject you to both civil and criminal penalties.